JP2017055769A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017055769A5 JP2017055769A5 JP2016252390A JP2016252390A JP2017055769A5 JP 2017055769 A5 JP2017055769 A5 JP 2017055769A5 JP 2016252390 A JP2016252390 A JP 2016252390A JP 2016252390 A JP2016252390 A JP 2016252390A JP 2017055769 A5 JP2017055769 A5 JP 2017055769A5
- Authority
- JP
- Japan
- Prior art keywords
- breast cancer
- level
- ube2c
- rna
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161557238P | 2011-11-08 | 2011-11-08 | |
| US61/557,238 | 2011-11-08 | ||
| US201261597426P | 2012-02-10 | 2012-02-10 | |
| US61/597,426 | 2012-02-10 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014540131A Division JP6147755B2 (ja) | 2011-11-08 | 2012-11-02 | 乳癌の予後を予測する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017055769A JP2017055769A (ja) | 2017-03-23 |
| JP2017055769A5 true JP2017055769A5 (enExample) | 2017-08-10 |
Family
ID=48290467
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014540131A Active JP6147755B2 (ja) | 2011-11-08 | 2012-11-02 | 乳癌の予後を予測する方法 |
| JP2016252390A Pending JP2017055769A (ja) | 2011-11-08 | 2016-12-27 | 乳癌の予後を予測する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014540131A Active JP6147755B2 (ja) | 2011-11-08 | 2012-11-02 | 乳癌の予後を予測する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US20140296085A1 (enExample) |
| EP (1) | EP2776830B1 (enExample) |
| JP (2) | JP6147755B2 (enExample) |
| AU (1) | AU2012336120B2 (enExample) |
| CA (1) | CA2854805C (enExample) |
| IL (4) | IL232445B (enExample) |
| MX (1) | MX357402B (enExample) |
| SG (2) | SG11201402042PA (enExample) |
| WO (1) | WO2013070521A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030198972A1 (en) | 2001-12-21 | 2003-10-23 | Erlander Mark G. | Grading of breast cancer |
| US9856533B2 (en) | 2003-09-19 | 2018-01-02 | Biotheranostics, Inc. | Predicting breast cancer treatment outcome |
| ES2667547T3 (es) | 2010-12-09 | 2018-05-11 | Biotheranostics, Inc. | Pronóstico de cáncer de mama después del tratamiento |
| WO2014044724A1 (en) * | 2012-09-18 | 2014-03-27 | Qiagen Gmbh | Method and kit for preparing a target rna depleted sample |
| WO2014110230A2 (en) * | 2013-01-09 | 2014-07-17 | Health Research, Inc. | Methods for diagnosing cancer based on small nucleolar rna hbii-52 |
| WO2014130444A1 (en) * | 2013-02-19 | 2014-08-28 | Genomic Health, Inc. | Method of predicting breast cancer prognosis |
| EP3044335B1 (en) * | 2013-09-11 | 2020-09-09 | Bio Theranostics, Inc. | Predicting breast cancer recurrence |
| EP3063689A4 (en) * | 2013-10-29 | 2017-08-30 | Genomic Health, Inc. | Methods of incorporation of transcript chromosomal locus information for identification of biomarkers of disease recurrence risk |
| CN105214077B (zh) * | 2014-06-03 | 2019-02-05 | 浙江阿思科力生物科技有限公司 | Usp33在肿瘤中的应用 |
| WO2016094330A2 (en) * | 2014-12-08 | 2016-06-16 | 20/20 Genesystems, Inc | Methods and machine learning systems for predicting the liklihood or risk of having cancer |
| EP3230911A1 (en) * | 2014-12-10 | 2017-10-18 | Koninklijke Philips N.V. | Methods and systems to generate noncoding-coding gene co-expression networks |
| WO2017040526A2 (en) * | 2015-09-01 | 2017-03-09 | Eisai R&D Management Co., Ltd. | Splice variants associated with neomorphic sf3b1 mutants |
| EP3719143B1 (en) | 2015-10-23 | 2023-07-26 | Novartis AG | Method of deriving a value for percent biomarker positivity for selected cells present in a field of view |
| US11530448B2 (en) | 2015-11-13 | 2022-12-20 | Biotheranostics, Inc. | Integration of tumor characteristics with breast cancer index |
| EP3202913B1 (en) * | 2016-02-08 | 2019-01-30 | King Faisal Specialist Hospital And Research Centre | A set of genes for use in a method of predicting the likelihood of a breast cancer patient's survival |
| CA3063450A1 (en) * | 2017-05-19 | 2018-11-22 | Lunella Biotech, Inc. | Companion diagnostics for mitochondrial inhibitors |
| US20190376115A1 (en) * | 2018-06-08 | 2019-12-12 | Glympse Bio, Inc. | Activity sensor design |
| CN108893537B (zh) * | 2018-07-19 | 2020-10-30 | 青岛泱深生物医药有限公司 | C7orf70及其应用 |
| JP2020028278A (ja) * | 2018-08-24 | 2020-02-27 | 国立大学法人九州大学 | 被検体に生じるイベントを予測するための判別器の生成方法、及び前記判別器を用いた被検体の層別化方法 |
| EP3874062A4 (en) * | 2018-11-04 | 2022-08-24 | PFS Genomics, Inc. | METHODS AND GENOMIC CLASSIFIERS FOR PRODICTING BREAST CANCER AND PREDICTING THE BENEFITS OF ADJUVANT RADIATION THERAPY |
| CN109859801B (zh) * | 2019-02-14 | 2023-09-19 | 辽宁省肿瘤医院 | 一种含有七个基因作为生物标志物预测肺鳞癌预后的模型及建立方法 |
| US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
| US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
| US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
| US20240218448A1 (en) * | 2020-04-23 | 2024-07-04 | Board Of Regents, The University Of Texas System | Methods and compositions related to full-length excised intron rnas (flexi rnas) |
| JP2023542867A (ja) | 2020-09-11 | 2023-10-12 | グリンプス バイオ， インコーポレイテッド | 疾患の検出／診断、病期分類、モニタリング及び処置のための生体外でのプロテアーゼ活性検出 |
| RU2763839C1 (ru) * | 2021-04-27 | 2022-01-11 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Петрова" Минздрава России) | Способ многофакторного прогноза рака молочной железы |
| CN113667749A (zh) * | 2021-08-03 | 2021-11-19 | 广东省人民医院 | 四个关键基因组合评估乳腺癌风险的诊断试剂盒 |
| CN114480650A (zh) * | 2022-02-08 | 2022-05-13 | 深圳市陆为生物技术有限公司 | 一种预测三阴乳腺癌临床预后复发风险的标志物及模型 |
| CN114657242B (zh) * | 2022-03-16 | 2022-11-11 | 广州医科大学附属第一医院 | Gpr33基因在马尔尼菲篮状菌易感人群评估的应用 |
| CN121137157B (zh) * | 2025-11-17 | 2026-02-10 | 长春科技学院 | 一种评估上皮性卵巢癌复发风险的试剂的用途 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3115470T3 (en) * | 2002-03-13 | 2018-11-05 | Genomic Health Inc | Gene Expression Profiling in Tumor Tissue Biopsies |
| US20040231909A1 (en) * | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
| US20050100933A1 (en) * | 2003-06-18 | 2005-05-12 | Arcturus Bioscience, Inc. | Breast cancer survival and recurrence |
| ES2905579T3 (es) * | 2003-07-10 | 2022-04-11 | Genomic Health Inc | Algoritmo del perfil de expresión y prueba para el pronóstico de la recaída del cáncer de mama |
| JP2005270093A (ja) * | 2004-02-24 | 2005-10-06 | Nippon Medical School | 乳癌の術後予後予測に関与する遺伝子 |
| CA2582739A1 (en) * | 2004-09-30 | 2006-04-13 | Bayer Healthcare Ag | Methods and kits for the prediction of therapeutic success and recurrence free survival in cancer therapy |
| WO2008046182A1 (en) * | 2006-09-15 | 2008-04-24 | Mcgill University | Stroma derived predictor of breast cancer |
| RU2473555C2 (ru) * | 2006-12-19 | 2013-01-27 | ДжинГоу, Инк. | Новые способы функционального анализа большого количества экспериментальных данных и групп генов, идентифицированных из указанных данных |
| EP2036988A1 (en) * | 2007-09-12 | 2009-03-18 | Siemens Healthcare Diagnostics GmbH | A method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent |
| WO2009071655A2 (en) * | 2007-12-06 | 2009-06-11 | Siemens Healthcare Diagnostics Inc. | Methods for breast cancer prognosis |
| US20110020370A1 (en) * | 2008-12-11 | 2011-01-27 | Elias Georges | Slc7a5 directed diagnostics and therapeutics for neoplastic disease |
| CN101851611A (zh) * | 2009-04-01 | 2010-10-06 | 天津医科大学附属肿瘤医院 | 驱动蛋白样蛋白kif1b的转移相关功能和预测肿瘤患者预后的标志物用途及其应用方法 |
| WO2010127399A1 (en) * | 2009-05-06 | 2010-11-11 | Walter And Eliza Hall Institute Of Medical Research | Gene expression profiles and uses thereof |
| EP2486154B1 (en) * | 2009-10-08 | 2017-03-01 | Wake Forest University Health Sciences | Diagnostic and prognostic markers for cancer |
| JP5964752B2 (ja) * | 2009-11-23 | 2016-08-03 | ジェノミック ヘルス， インコーポレイテッド | 癌の臨床転帰を予測する方法 |
| US20120245235A1 (en) * | 2009-12-01 | 2012-09-27 | Compenda Bioscience, Inc | Classification of cancers |
| GB0922437D0 (en) * | 2009-12-22 | 2010-02-03 | Cancer Rec Tech Ltd | Hypoxia tumour markers |
| US20130143753A1 (en) * | 2010-03-01 | 2013-06-06 | Adelbio | Methods for predicting outcome of breast cancer, and/or risk of relapse, response or survival of a patient suffering therefrom |
| PL2553118T3 (pl) * | 2010-03-31 | 2015-03-31 | Sividon Diagnostics Gmbh | Sposób przewidywania nawrotu raka sutka podczas leczenia endokrynologicznego |
-
2012
- 2012-11-02 WO PCT/US2012/063313 patent/WO2013070521A1/en not_active Ceased
- 2012-11-02 SG SG11201402042PA patent/SG11201402042PA/en unknown
- 2012-11-02 AU AU2012336120A patent/AU2012336120B2/en active Active
- 2012-11-02 MX MX2014005547A patent/MX357402B/es active IP Right Grant
- 2012-11-02 JP JP2014540131A patent/JP6147755B2/ja active Active
- 2012-11-02 US US14/355,642 patent/US20140296085A1/en not_active Abandoned
- 2012-11-02 SG SG10202010758SA patent/SG10202010758SA/en unknown
- 2012-11-02 EP EP12847964.9A patent/EP2776830B1/en active Active
- 2012-11-02 CA CA2854805A patent/CA2854805C/en active Active
-
2014
- 2014-05-04 IL IL232445A patent/IL232445B/en active IP Right Grant
-
2016
- 2016-01-29 US US15/011,206 patent/US20160222463A1/en not_active Abandoned
- 2016-12-27 JP JP2016252390A patent/JP2017055769A/ja active Pending
-
2018
- 2018-09-12 IL IL261708A patent/IL261708A/en unknown
-
2019
- 2019-01-17 US US16/250,179 patent/US20190256923A1/en not_active Abandoned
- 2019-03-03 IL IL265136A patent/IL265136B/en active IP Right Grant
-
2020
- 2020-02-07 US US16/784,696 patent/US20200263257A1/en not_active Abandoned
- 2020-08-04 IL IL276488A patent/IL276488B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017055769A5 (enExample) | ||
| Bach et al. | Long noncoding RNAs in cancer cells | |
| JP2010538609A5 (enExample) | ||
| JP2020031642A5 (enExample) | ||
| JP2016174600A5 (enExample) | ||
| Ahadi | Functional roles of lncRNAs in the pathogenesis and progression of cancer | |
| Lin et al. | Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significance | |
| JP2014532428A5 (enExample) | ||
| JP2016214245A5 (enExample) | ||
| UA110790C2 (uk) | Спосіб передбачування рецидиву раку молочної залози при ендокринному лікуванні | |
| JP2009523028A5 (enExample) | ||
| NZ600268A (en) | Method to use gene expression to determine likelihood of clinical outcome of renal cancer | |
| JP2019524884A5 (enExample) | ||
| EP4428157A3 (en) | Use of immune cell-specific gene expression for prognosis of prostate cancer and prediction of responsiveness to radiation therapy | |
| JP2014509189A5 (enExample) | ||
| JP2018527886A5 (enExample) | ||
| Sun et al. | Clinical significance of the decreased expression of hsa_circ_001242 in oral squamous cell carcinoma | |
| WO2010118166A3 (en) | Methods of predicting cancer risk using gene expression in premalignant tissue | |
| JP2016537010A5 (enExample) | ||
| JP2016533708A5 (enExample) | ||
| WO2016130572A3 (en) | Methods of determining levels of exposure to radiation and uses thereof | |
| CN110055327A (zh) | 用于预测癌症免疫治疗效果的内皮细胞标记物与试剂盒 | |
| EP4427804A3 (en) | Methods of diagnosing cancer | |
| JP2017195803A5 (enExample) | ||
| EA201290107A1 (ru) | Способ определения пациента как восприимчивого или не восприимчивого к иммунотерапии |